Behaviours and Health Risks, Burnet Institute, Melbourne, Australia.
School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
J Stud Alcohol Drugs. 2021 Mar;82(2):188-196.
Ketamine is a dissociative anesthetic used in medical practice, used recreationally since the mid-1960s. This study describes trends in ketamine use in sentinel cross-sectional samples of Australians who regularly use illicit stimulants, along with characteristics of consumers.
Data on trends in recent ketamine use (i.e., use in past 6 months) were drawn from annual interviews (approximately 800/year) with cross-sectional samples of people recruited from Australian state capitals from 2009 to 2019 as part of the Ecstasy and Related Drugs Reporting System (EDRS) study. Characteristics of those reporting recent use were examined in the 2019 EDRS data set (n = 728) using logistic regression.
Recent ketamine use increased between 2009 and 2019 (10% to 41%, respectively, p < .001), primarily driven by use among participants recruited in Melbourne (21% to 84%, p < .001) and Sydney (19% to 68%, p < .001). However, frequency of use remained low. In 2019, consumer characteristics associated with use included being born outside of Australia and residing in Sydney or Melbourne (compared with Canberra).
Among EDRS participants in Australia, we observed an increase in recent ketamine use between 2009 and 2019, although indicators of potential problematic use remained low. The increase in recent ketamine use was largely driven by increases in Melbourne and Sydney. Further research on drivers of use in these cities is required to effectively inform harm-reduction strategies.
氯胺酮是一种在医学实践中使用的分离性麻醉剂,自 20 世纪 60 年代中期以来,被人们在娱乐活动中使用。本研究描述了在澳大利亚定期使用非法兴奋剂的代表性横断面样本中,氯胺酮使用的趋势,以及消费者的特点。
从 2009 年至 2019 年,作为摇头丸和相关毒品报告系统(EDRS)研究的一部分,从澳大利亚首府招募的横断面样本中,每年进行一次年度访谈(每年约 800 次),以获取最近(即过去 6 个月内)使用氯胺酮的数据。在 2019 年 EDRS 数据集(n=728)中,使用逻辑回归检查报告最近使用的特征。
最近的氯胺酮使用量在 2009 年至 2019 年之间有所增加(分别为 10%至 41%,p<0.001),主要是由于墨尔本(21%至 84%,p<0.001)和悉尼(19%至 68%,p<0.001)参与者的使用增加所致。然而,使用频率仍然很低。在 2019 年,与使用相关的消费者特征包括在澳大利亚境外出生和居住在悉尼或墨尔本(与堪培拉相比)。
在澳大利亚 EDRS 参与者中,我们观察到 2009 年至 2019 年期间最近使用氯胺酮的人数有所增加,尽管潜在问题使用的指标仍然很低。最近氯胺酮使用的增加主要是由于墨尔本和悉尼的增加所致。需要对这些城市使用氯胺酮的驱动因素进行进一步研究,以有效地为减少伤害战略提供信息。